Stockscreener 앱 받기
55.07
0.67%
-0.37
전일 마감가:
$55.44
열려 있는:
$55.26
하루 거래량:
94,026
Relative Volume:
0.03
시가총액:
$128.86B
수익:
$48.62B
순이익/손실:
$6.80B
주가수익비율:
19.64
EPS:
2.8038
순현금흐름:
$7.62B
1주 성능:
+4.38%
1개월 성능:
+5.94%
6개월 성능:
+4.20%
1년 성능:
+12.36%
1일 변동 폭
$55.02
$55.29
1주일 범위
$52.94
$55.73
52주 변동 폭
$45.80
$60.12
사노피 ADR Stock (SNY) Company Profile
SNY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNY
Sanofi Adr
|
55.07 | 128.86B | 48.62B | 6.80B | 7.62B | 2.8038 |
|
LLY
Lilly Eli Co
|
822.50 | 739.75B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
155.01 | 370.90B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
196.50 | 340.25B | 57.37B | 4.20B | 17.83B | 2.35 |
|
NVO
Novo Nordisk Adr
|
69.41 | 277.97B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
113.55 | 222.45B | 53.22B | 12.86B | 14.85B | 6.39 |
사노피 ADR Stock (SNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 개시 | Exane BNP Paribas | Outperform |
| 2025-03-21 | 개시 | Goldman | Neutral |
| 2025-01-30 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-07-26 | 재확인 | Argus | Buy |
| 2024-01-23 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-01-16 | 재개 | UBS | Buy |
| 2023-12-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-10-30 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-09-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-28 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-03-27 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-12-13 | 재개 | Morgan Stanley | Overweight |
| 2022-08-12 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-08-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-09-27 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-01-15 | 개시 | Deutsche Bank | Sell |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-03-17 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-03-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-02-11 | 개시 | SVB Leerink | Mkt Perform |
| 2020-01-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-03 | 개시 | Bernstein | Outperform |
| 2019-08-14 | 업그레이드 | UBS | Neutral → Buy |
| 2018-12-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-11-01 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-10-09 | 개시 | Guggenheim | Neutral |
| 2018-09-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-08-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-03-23 | 업그레이드 | Liberum | Hold → Buy |
| 2018-01-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2017-12-06 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-12-01 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2017-11-15 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2017-08-30 | 업그레이드 | HSBC Securities | Reduce → Hold |
모두보기
사노피 ADR 주식(SNY)의 최신 뉴스
BIDU’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
A Tale of Resilience: Sanofi ADR Amid Stock Market Turbulence - investchronicle.com
Trip.com Group Ltd ADR (TCOM) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
CYTK’s 2023 Market Dance: Down -21.41% – Time to Invest? - investchronicle.com
CIG’s Market Whiplash: 8.19% YTD Rise, 9.30% Rise in 30 Days - investchronicle.com
LX’s 2023 Market Dance: Up 43.28% – Time to Invest? - investchronicle.com
Companhia Siderurgica Nacional ADR (SID) Stock: From Low to High in 52 Weeks - investchronicle.com
The Future of EVgo Inc: Analyzing EVGO - investchronicle.com
NVS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
Unilever plc ADR: Rising -3.90% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com
Sap SE ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Jumia Technologies Ag ADR (JMIA) Stock: A Comprehensive 52-Week Review - investchronicle.com
Viking Holdings Ltd’s Banking’s 100-Day Moving Average at 44.43: Will the Stock Break Through? - investchronicle.com
Sandisk Corp (SNDK) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
LATAM Airlines Group S.A. ADR’s Banking’s 100-Day Moving Average at 29.99: Will the Stock Break Through? - investchronicle.com
TME’s Market Whiplash: 24.39% YTD Rise, -2.43% Plunge in 30 Days - investchronicle.com
Sumitomo Mitsui Financial Group Inc ADR (SMFG) Stock: A Year of Market Movement, Down and Up - investchronicle.com
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Mars 2025 - GlobeNewswire Inc.
Vipshop Holdings Ltd ADR Inc. (VIPS) Price Performance: The Role of Supply and Demand - investchronicle.com
Wellchange Holdings Co. Ltd (WCT) Stock: A Year of Decreases and Increases - investchronicle.com
Longevity Health Holdings Inc Inc. (XAGE) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
ModivCare Inc (MODV) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
AMRX’s Financial Health: Exploring Amneal Pharmaceuticals Inc’s Debt-to-Equity Ratio of 1.79 - investchronicle.com
Childrens Place Inc Inc. (PLCE) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
Stocks With Rising Relative Price Strength: Smith & Nephew ADR - inkl
Stocks With Rising Relative Strength: Belden - inkl
ZTO Express [Cayman] Inc ADR [ZTO] is -2.81% lower this YTD. Is it still time to buy? - dbtnews.com
For Sanofi ADR [SNY], Analyst sees a rise to $65. What next? - dbtnews.com
MaxLinear Inc [MXL] Stock trading around $9.65 per share: What’s Next? - dbtnews.com
European Drug Giants Report. But Only One Beats Sales Views. - Investor's Business Daily
There is no doubt that Sanofi ADR (SNY) ticks all the boxes. - Sete News
Sanofi ADR earnings beat by $0.12, revenue fell short of estimates - Investing.com Canada
Views of Wall Street’s Leading Experts on TIM SA ADR - Sete News
Potential Price Increase for RELX Plc ADR (RELX) After Recent Insider Activity - knoxdaily.com
SPR’s latest rating updates from top analysts. - knoxdaily.com
Analysts review Sanofi ADR’s rating - knoxdaily.com
Rio Tinto plc ADR (RIO) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Potential Price Increase for ING Groep N.V. ADR (ING) After Recent Insider Activity - knoxdaily.com
Scotiabank Downgrades Braskem S.A. ADR (BAK) to a Sector perform from a Sector outperform - knoxdaily.com
Chemours Company [CC] Stock sold by Insider Scarborough Alvenia for $0.15 million - knoxdaily.com
The Potential Rise in the Price of OneMain Holdings Inc (OMF) following insiders activity - knoxdaily.com
F.N.B. Corp [FNB] Insider MOTLEY DAVID L sells 15,000 Shares – Insider Selling Alert - knoxdaily.com
Cognizant Technology Solutions Corp (CTSH) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Recent Insider Activity Suggests Potential Gains for Honeywell International Inc (HON) - knoxdaily.com
Potential Price Increase for Klaviyo Inc (KVYO) After Recent Insider Activity - knoxdaily.com
Keeping an Eye on Interpublic Group Of Cos., Inc (IPG) After Insider Trading Activity - knoxdaily.com
Webster Financial Corp [WBS] Stock sold by Insider CIULLA JOHN R for $0.46 million - knoxdaily.com
The Potential Rise in the Price of Hologic, Inc (HOLX) following insiders activity - knoxdaily.com
60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Communiqué de presse - GlobeNewswire Inc.
Selling Buzz: Insmed Inc [INSM] Chair and CEO Lewis William sells 6,830 shares of the company - knoxdaily.com
사노피 ADR (SNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
1.01%
자본화:
|
볼륨(24시간):